DIEPSS（英語版）

1. Process of Development of the DIEPSS

1. Before the development of the DIEPSS in Japan
2. Suspension of the development of a Japanese version of the SAS
3. Suspension of the development of a Japanese version of the ESRS
4. Establishment of the DIEPSS
5. Advantage of using the DIEPSS

2. General comments for using the DIEPSS

1. Each evaluation should be made independently
2. The highest anchor point should be chosen
3. The severest symptoms should be evaluated
4. Repeat evaluations should be made at the same time of day
5. How to handle the rating ‘1 (minimal, questionable)’
6. How to handle EPS not of drug-induced origin
7. Differentiation between the continuous and intermittent states

3. DIEPSS Individual Items

1. Subclassification
2. Parkinsonism
3. Akathisia
4. Dystonia
5. Dyskinesia
6. Overall Severity of Extrapyramidal Symptoms

4. Reliability of the DIEPSS

1. Inter-rater Reliability
2. Test-retest Reliability
3. Training Utilities

5. Validity of the DIEPSS

1. Factor Structure
2. Concurrent Validity
3. Evaluation of Optimal Cut-Off Scores
4. Predictive Validity

6. Clinical application of the DIEPSS

1. Comparison of EPS profiles between typical and atypical antipsychotics
2. Preventive Strategies for EPS using the DIEPSS
3. Other clinical and biological studies

Appendix

1. Japanese version
2. Chinese version
3. Taiwanese version
4. Korean version
5. English version